Found: 3
Select item for more details and to access through your institution.
Effect of Nintedanib in Subgroups of Idiopathic Pulmonary Fibrosis by Diagnostic Criteria.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Phase 2 trial of afatinib, an ErbB family blocker, in solid tumors genetically screened for target activation.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 16, p. 3043, doi. 10.1002/cncr.28120
- By:
- Publication type:
- Article
Weight-Loss Effect on FVC in Nintedanib Idiopathic Pulmonary Fibrosis Trials?
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2015, v. 192, n. 8, p. 1020, doi. 10.1164/rccm.201507-1354le
- By:
- Publication type:
- Article